GH peer analysis
Guardant Health (GH) against its competitors: price, today's move, 1-year return and market value side by side.
GH and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDSX Biodesix | $23.25 | -5.93% | 253.96% | – |
| BLLN BillionToOne | $109.31 | -3.54% | – | – |
| BNR Burning Rock | $11.05 | -6.91% | -5.56% | $114.96M |
| CSTL Castle Biosciences | $35.28 | -5.06% | 45.72% | $1.14B |
| FLGT Fulgent Genetics | $20.62 | -4.89% | -8.68% | $567.37M |
| GRAL GRAIL | $134.98 | -5.89% | 58.41% | – |
| MYGN Myriad Genetics | $5.89 | -7.17% | -25.85% | $607.38M |
| NEO NeoGenomics | $16.78 | -3.45% | 73.17% | $2.25B |
| NTRA Natera | $387.31 | -6.51% | 100.45% | $59.72B |
| PSNL Personalis | $15.85 | 0.19% | 66.67% | $1.69B |
| GH Guardant Health | $172.67 | -3.43% | 86.85% | $23.99B |
- GH's peers: BDSX (Biodesix), BLLN (BillionToOne), BNR (Burning Rock), CSTL (Castle Biosciences), FLGT (Fulgent Genetics), GRAL (GRAIL), MYGN (Myriad Genetics), NEO (NeoGenomics).
Updated 2026-11-02 19:10 UTC